FDA increases age restrictions for birth control
Many birth control advertisements have two things in common: A happy woman and a long list of risks. By law, those risks must be conveyed, and in December, the U.S. Food and Drug Administration ruled that the labels for Yaz and Yasmin needed to better communicate the high risks of blood clots.






